Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment.
Big Market Research, Global Liver Diseases Therapeutics Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, 2013 – 2020. Liver diseases are one of the most prevalent diseases in the world. The commercialization of variety of liver therapeutics drugs has made the treatment of these diseases possible. The report provides an in-depth intelligence about current market trends of liver diseases therapeutics market. The objective of this report is to study the demand these therapeutics in the market and to assess its growth.
VISIT HERE @ https://www.grandresearchstore.com/healthcare/global-liver-diseases-therapeutics-drugs-market-professional-survey-report-2017 This report provided by GrandResearchStore is about,This report studies Liver Diseases Therapeutics Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
Primary Biliary Cholangitis (PBC), previously known as primary biliary cirrhosis, is a chronic, autoimmune liver disease that primarily affects the bile ducts within the liver. This condition, characterized by the progressive destruction of the bile ducts, can lead to the accumulation of bile acids and toxins, eventually resulting in liver damage and dysfunction. The management of PBC has witnessed significant advancements in recent years, with a range of therapeutic options offering improved outcomes and enhanced quality of life for patients. This article aims to provide an insightful analysis of the evolving landscape of PBC therapeutics, highlighting the key treatments and emerging trends shaping the market. Know More- https://www.alliedmarketresearch.com/primary-biliary-cholangitis-pbc-therapeutics-market-A108539
The report covers Vietnam healthcare market size, market segmentation by hospitals & clinics, diagnostic labs, pharmaceutical and medical devices.. For more information on the research report, refer to below link: https://www.kenresearch.com/healthcare/general-healthcare/vietnam-healthcare-market-report/142714-91.html
Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease, it remains a serious global health concern. Incidence tends to be higher in countries with a significant number of migrants from medium and high-prevalence countries. Enquiry @ http://www.researchbeam.com/hepatitis-b-therapeutics-in-major-developed-to-2021-increasing-number-of-migrants-from-high-prevalence-regions-to-drive-growth-market/enquire-about-report
Curcumin is yellow coloured fat soluble polyphenolic pigment that is derived from curcuminoids. It is also recognized as turmeric extract. Asian consumers are demanding for personal and ayurvedic personal care products free from synthetic and harmful chemical products.
The global hepatitis therapeutics market size was valued at $14,480 Million in 2020 and is projected to reach $19,716 Million by 2030 registering a CAGR of 3.1% from 2021 to 2030.
According to the latest research report by IMARC Group, The global liver disease treatment market size reached US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. More Info:- https://www.imarcgroup.com/liver-disease-treatment-market
Liquid biopsy reduces the apprehension of patients regarding pain and provides a safe and effective method of diagnosis. As a result, there has been increasing demand for a non-invasive alternative, such as liquid biopsy, over tissue biopsy that involves the painful extraction of diseased tissue, which is fueling the market growth. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/liquid-biopsy-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
This report provides top line data relating to the clinical trials on Liver Transplant Rejection... To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/liver-transplant-rejection-global-clinical-trials/142650-91.html
Global Transplantation market to grow at a CAGR of 9.36 percent over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/global-transplantation-2015-2019-market
The rising prevalence of chronic diseases, including obesity and diabetes, is among the key factors driving the US insulin market. In addition to this, the escalating demand for insulin therapeutics is further propelling the market growth. Moreover, the growing requirement for biosimilar drugs, owing to their high efficiency and cost-effectiveness, is acting as another significant growth-inducing factor.
Pruritus is a primary skin disorder that results in an unpleasant sensation that provokes the desire to itch or scratch. In other words, pruritus is a dermatological disorder that leads to severe and vigorous itching. The intensity of itching ranges from mild itchiness to insistent.
The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. Enquiry @ http://www.researchbeam.com/frontier-pharma-liver-cancer-identifying-and-commercializing-first-in-class-innovation-market/enquire-about-report
Big Market Research present “Global Gaucher Disease Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-gaucher-disease-2015-2019-market Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow.
Big Market Research presents this report which features an analysis of granted patent applications in the liver cancer market, which was used as an indication of innovation at the earliest stage of product development. Read The Complete Report On : http://www.bigmarketresearch.com/frontier-pharma-liver-cancer-identifying-and-commercializing-first-in-class-innovation-market
Analyze Future: Liver Cancer Treatment Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/liver-cancer-treatment-drugs-in-china-market China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.
Liver disease comprises of wide range of complex conditions affecting the liver. Liver disease treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications.
Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally. Some people may have no symptoms of this disease, while some experience severe complications. Some of the clinical manifestations of this disease are hepatosplenomegaly, anemia, thrombocytopenia, and skeletal abnormalities. Read more details @ http://www.bigmarketresearch.com/global-gaucher-disease-2015-2019-market
The global stem cell therapy market size is accounted to grow at a significant CAGR of over 35% over the forecast period 2021 to 2027 and expected to reach around USD 4 billion by 2027. The rising incidence of chronic disease across the globe is a primary factor to drive the market growth. Rapid growth in the rate of cancer is further propelling the market. According to the latest information shared by the American Cancer Society, it is estimated that 1.8 million new cases were diagnosed in 2020, and 606,520 deaths recorded due to cancer in the United States.
GBI Research, the leading business intelligence provider, has released its latest research: Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in the eight major geographies of the US, Canada, the UK, France, Germany, Spain, Italy and Japan. The report provides an estimation of the market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth pipeline analysis, and deal analysis. Enquiry @ http://www.researchbeam.com/colorectal-cancer-therapeutics-in-major-developed-to-2020-increased-uptake-of-high-priced-drugs-to-offset-the-impact-of-generics-market/enquire-about-report
Global pruritus drug market is growing at a substantial CAGR in the forecast period of 2019-2026. Increasing research and development expenses and high demand of novel therapies are some factors fueling the market growth
Big Market Research has announced a new Report Package " Global Chronic Lymphocytic Leukemia Therapeutics Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/global-chronic-lymphocytic-leukemia-therapeutics-2015-2019-market Chronic lymphocytic leukemia is a malignant condition characterized by increased production of lymphocytes. It has been observed that the cancer first affects B-lymphocytes and then it can spread to other parts of the body. This leukemia is diagnosed mostly at later stages because of the slow buildup of the cancerous cells. During the course of the disease, the malignancy spreads to the spleen, liver, and lymph nodes. The course of the disease is heterogeneous, and prognosis is difficult. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/280094
Big Market Research, Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trails, H1, Market Review, Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, 2015.clinical trial report, "Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. Get more about this report at: http://www.bigmarketresearch.com/frontier-pharma-liver-cancer-identifying-and-commercializing-first-in-class-innovation-market
Big Market Research has announced a new Report Package "Global Acute Myeloid Leukemia Therapeutics Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-acute-myeloid-leukemia-therapeutics-2015-2019-market Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic of acute myeloid leukemia. Enquire At: http://www.bigmarketresearch.com/report-enquiry/169995
Pruritus is referring to the severe itching associated with number of dermatological disorders including xerotic eczema, atopic dermatitis, and allergic contact dermatitis. It is typically an unpleasant sensation that elicits a desire to scratch vigorously and it is greatly altered by psychological and CNS factors.
Big Market Research has announced a new Report Package "Hepatitis B Therapeutics Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2021" Get Complete Report at: http://www.bigmarketresearch.com/hepatitis-b-therapeutics-in-major-developed-to-2021-increasing-number-of-migrants-from-high-prevalence-regions-to-drive-growth-market Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and characterized by acute or chronic inflammation of the liver. Despite its status as a vaccine-preventable disease, it remains a serious global health concern. I Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/332029
Big Market Research presents this report which provides an estimation of the market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth pipeline analysis, and deal analysis. Read The Complete Report On : http://www.bigmarketresearch.com/colorectal-cancer-therapeutics-in-major-developed-to-2020-increased-uptake-of-high-priced-drugs-to-offset-the-impact-of-generics-market
The Ascites market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Ascites market.
According to #TechSci Research report, Global In Silico Clinical Trials Market is projected to accomplish an extraordinary growth in the forecast period, 2022-2026 with an impressive CAGR. Gain More Insight: https://bit.ly/3yPyIRr Get Sample Report: https://bit.ly/3jRZh4h Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
According to #TechSci Research report, India Anti-Fungal Drugs Market is expected to reach US$ 1562.73 million, growing at a double digit CAGR of 10.49% by FY2027. Gain More Insight: https://bit.ly/3ph73aO Get Sample Report: https://bit.ly/3vks6KJ Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Cancer Biomarkers Market Information By Type (Genetic Biomarkers, Epigenetic Biomarkers, Proteomic Biomarkers, Glycoprotein Biomarkers), Disease Type, Profiling Technologies and Application: Forecast To 2027
The global anti-infective drugs market was valued at around $117 billion in 2017. North America was the largest region in the anti-infective drugs market in 2017, accounting for 30% market share. Read Report https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report-2018
GLP-1 Receptor Agonist Market, By Drug Type (Exenatide, Liraglutide, Dulaglutide, Semaglutide, and others), Brand (Bydureon, Victoza, Trulicity, Ozempic, and Others), Route of Administration (Injectable, Oral Formulations), Application (Type 2 Diabetes, Obesity, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the biochemical and physiological well-being of the humans. They are also used to confirm the proper functioning of vital organs such as liver, kidney and thyroid and to understand the effectiveness of given therapeutics.
According to the latest research report by IMARC Group, The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. More Info:- https://www.imarcgroup.com/organ-on-chip-market
Nonalcoholic Steatohepatitis (NASH) also known as “silent disease” is a type of fatty liver disease, which mainly affects people with diabetes and obesity. Symptoms of NASH are found among all demographics (from children to adults); however, they are more prevalent in younger people. Corner stage of cirrhosis is a form of NASH that can be reversed with proper medication. Moreover, most of the NASH specific pharmaceutical solution are in clinical trial phase .
Big Market Research adds a report " Alcoholic Hepatitis Market- Clinical Trials Review, Size, Share, Trends, Forecast " Get Complete Report @ http://www.bigmarketresearch.com/alcoholic-hepatitis-global-clinical-trials-review-h2-2015-market This report provides top line data relating to the clinical trials on Alcoholic Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/381412
According to the latest research report by IMARC Group, The global hyperlipidemia drugs market size reached US$ 22.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.8 Billion by 2032, exhibiting a growth rate (CAGR) of 1.8% during 2024-2032. More Info:- https://www.imarcgroup.com/hyperlipidemia-drugs-market
Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the biochemical and physiological well-being of the humans. They are also used to confirm the proper functioning of vital organs such as liver, kidney and thyroid and to understand the effectiveness of given therapeutics. Read more details: https://goo.gl/VV457W
According to the latest research report by IMARC Group, The global 3D printing in healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.2% during 2024-2032. More Info:- https://www.imarcgroup.com/3d-printing-in-healthcare-market
Big Market Research, Steatohepatitis Global Clinical Trials Market Review, Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015.clinical trial report, "Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data on the Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each.
Big Market Research, Post Operative Nausea And Vomiting, Global Clinical Trials, H1 Market Review, Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, 2015. This clinical trial report, "Post Operative Nausea And Vomiting Global Clinical Trials Review, H1, 2015" provides data on the Post Operative Nausea And Vomiting clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Operative Nausea And Vomiting. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
Deficiency of the enzymes of peroxisomal -oxidation has been recognized as an ... Thus, although symptoms of liver disease rarely develop in p'ts with fatty liver ...